Effect of Marma Chikitsa on Vatashthila (Benign Prostate Hyperplaisa)
- Conditions
- Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: VATASHTHILA, (2) ICD-10 Condition: N33||Bladder disorders in diseases classified elsewhere. Ayurveda Condition: VATASHTHILA (Benign Prostate Hyperplasia),
- Registration Number
- CTRI/2023/03/051080
- Lead Sponsor
- Pandit Khushilal Sharma Government Autonomous Ayurveda College and Institute Bhopal MP
- Brief Summary
IN THIS STUDY DETAILS OF MUTRAGHAT WITH SPECIAL REFRENCE TO VATASHTHILA AND THE MODERN REFERENCE OF BENIGN PROSTATE HYPERPLASIA WILL BE DONE FROM LITERATURE.
WE WILL EVALUATE THE EFFECT OF MARMA CHIKITSA IN THE MANAGEMENT OF MUTRAGHAT WITH SPECIAL REFRENCE TO VATASHTHILA (BPH).
The initial assessment included the
**International Prostatic Symptoms Score (IPSS)**
The International Prostate Symptom Score (I-PSS) is based on the answers to seven
Questions concerning urinary symptoms.. Each question concerning urinary symptoms
allows the patient to choose one out of six answers indicating increasing severity of the
Particular symptom. The answers are assigned points from 0 to 5.
Thetotal score can therefore range from 0 to 35 (asymptomatic to very symptomatic).The questions refer to the following urinary symptoms: Questions included in I-PSS score..
1 Incomplete emptying 2 Frequency 3 Intermittency 4 Urgency5 Weak Stream
6 Straining7 Nocturia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Male
- Target Recruitment
- 30
- 1.The Patients with IPSS International prostatic Symptom Score (0-7) Mild and ( 8-19 )Moderate.
- 2.Patient willing to be registered for study with written consent.
- 3.Patient having BMI less than 30 kg/m2.
- 1.Patients below the age of 45 years and above 85 years.
- 2.Patient having BMI more than 30kg/m2.
- 3Patient with IPSS International Prostatic Symptom score (19-35)Severe.
- 4Patient with any severe illness Like Tuberculosis, Cardiac Disease ,Liver disease or Any Malignancy.
- 5.Patient having severe psychiatric illness.
- 6.Patients not willing for written consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected that at the end of study, scholar will be able to evaluate Effect of Marma Chikitsa in the Management of Mutraghat with special reference to Vatashthila (Benign Prostate Hyperplasia)1Incomplete emptying 2 Frequency 3 Intermittency 4 Urgency5 Weak Stream It is expected that at the end of 3 months, scholar will be able to evaluate Effect of Marma Chikitsa in the Management of Mutraghat with special reference to Vatashthila (Benign Prostate Hyperplasia)1Incomplete emptying 2 Frequency 3 Intermittency 4 Urgency5 Weak Stream | 6 Straining7 Nocturia 6 Straining7 Nocturia It is expected that at the end of 3 months, scholar will be able to evaluate Effect of Marma Chikitsa in the Management of Mutraghat with special reference to Vatashthila (Benign Prostate Hyperplasia)1Incomplete emptying 2 Frequency 3 Intermittency 4 Urgency5 Weak Stream | 6 Straining7 Nocturia
- Secondary Outcome Measures
Name Time Method It is expected that at the end of study, scholar will be able to evaluate Effect of Marma Chikitsa in the Management of Mutraghat with special reference to Vatashthila (Benign Prostate Hyperplasia) It is expected that at the end of 3 months, scholar will be able to evaluate Effect of Marma Chikitsa in the Management of Mutraghat with special reference to Vatashthila (Benign Prostate Hyperplasia)
Trial Locations
- Locations (1)
Pandit Khushilal Sharma Government Autonomous College and Institute Bhopal MP
🇮🇳Bhopal, MADHYA PRADESH, India
Pandit Khushilal Sharma Government Autonomous College and Institute Bhopal MP🇮🇳Bhopal, MADHYA PRADESH, IndiaDr Ashwarya VijayvargiyaPrincipal investigator9981306425aishwaryavijaywargiya65@gmail.com